Jeffrey F Scherrer1,2, Joanne Salas1,2, Patrick J Lustman3, Carissa van den Berk-Clark1, Paula P Schnurr4,5, Peter Tuerk6,7, Beth E Cohen8,9, Matthew J Friedman4, Sonya B Norman4,10, F David Schneider11, Kathleen M Chard12,13. 1. Department of Family and Community Medicine, Saint Louis University School of Medicine, St. Louis, Missouri. 2. Harry S. Truman Veterans Administration Medical Center, Columbia, Missouri. 3. Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri. 4. National Center for PTSD, White River Junction, Vermont. 5. Department of Psychiatry, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire. 6. Ralph H. Johnson VA Medical Center, Charleston, South Carolina. 7. Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston. 8. Department of Medicine, University of California San Francisco School of Medicine, San Francisco. 9. San Francisco VA Medical Center, San Francisco, California. 10. Department of Psychiatry, University of California, San Diego. 11. Department of Family and Community Medicine, University of Texas Southwestern, Dallas. 12. Trauma Recovery Center Cincinnati VA Medical Center, Cincinnati, Ohio. 13. Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, Cincinnati, Ohio.
Abstract
Importance: Posttraumatic stress disorder (PTSD) is associated with an increased risk of type 2 diabetes mellitus (T2DM). Existing literature has adjusted for obesity in combination with other confounders, which does not allow estimating the contribution of obesity alone on the association of PTSD with incident T2DM. Objective: The current study was designed to determine if obesity accounted for the association between PTSD and incident T2DM. Design, Setting, and Participants: This cohort study used data from Veterans Health Administration medical records collected from patients with PTSD and without PTSD from 2008 to 2015. Patients were eligible for study inclusion if they were free of prevalent PTSD and T2DM for 12 months prior to index date. To estimate whether the association of PTSD and incident T2DM remained independent of obesity, Cox proportional hazard models were computed before and after adding obesity to the model and then further expanded by adding psychiatric disorders, psychotropic medications, physical conditions, smoking status, and demographics. Additional Cox models were computed to compare the risk of incident T2DM in patients with PTSD with and without obesity. Data analysis was completed from February 2018 to May 2018. Exposures: Two International Classification of Diseases, Ninth Revision (ICD-9) codes for PTSD in the same 12 months and obesity, defined by a body mass index of 30 or more or an ICD-9 code for obesity. Main Outcomes and Measures: Incident T2DM, as defined by ICD-9 codes. Results: Among 2204 patients without PTSD, the mean (SD) age was 47.7 (14.3) years; 1860 (84.4%) were men, 1426 (64.7%) were white, and 956 (43.4%) were married. Among 3450 patients with PTSD, the mean (SD) age was 42.8 (14.2) years; 2983 (86.5%) were men, 2238 (64.9%) were white, and 1525 (44.2%) were married. The age-adjusted association between PTSD and incident T2DM was significant (hazard ratio [HR], 1.33 [95% CI, 1.08-1.64]; P = .01), and after adding obesity to the model, this association was reduced and no longer significant (HR, 1.16 [95% CI, 0.94-1.43]; P = .18). Results of the full model, which included additional covariate adjustment, revealed no association between PTSD and incident T2DM (HR, 0.84 [95% CI, 0.64-1.10]; P = .19). Among patients with PTSD with obesity, the age-adjusted incidence of T2DM was 21.0 per 1000 person-years vs 5.8 per 1000 person-years in patients without obesity. In patients without PTSD, it was 21.2 per 1000 person-years for patients with obesity vs 6.4 per 1000 person-years in those without obesity. Conclusions and Relevance: In this study of patients who use the Veterans Health Administration for health care, obesity moderated the association between PTSD and incident T2DM. The incidence of T2DM in patients with PTSD who are not obese is similar to the national incidence rate in the United States. These results suggest PTSD is not likely to have a causal association with incident T2DM. Future research is needed to determine if PTSD remission can lead to weight loss and reduced T2DM incidence.
Importance: Posttraumatic stress disorder (PTSD) is associated with an increased risk of type 2 diabetes mellitus (T2DM). Existing literature has adjusted for obesity in combination with other confounders, which does not allow estimating the contribution of obesity alone on the association of PTSD with incident T2DM. Objective: The current study was designed to determine if obesity accounted for the association between PTSD and incident T2DM. Design, Setting, and Participants: This cohort study used data from Veterans Health Administration medical records collected from patients with PTSD and without PTSD from 2008 to 2015. Patients were eligible for study inclusion if they were free of prevalent PTSD and T2DM for 12 months prior to index date. To estimate whether the association of PTSD and incident T2DM remained independent of obesity, Cox proportional hazard models were computed before and after adding obesity to the model and then further expanded by adding psychiatric disorders, psychotropic medications, physical conditions, smoking status, and demographics. Additional Cox models were computed to compare the risk of incident T2DM in patients with PTSD with and without obesity. Data analysis was completed from February 2018 to May 2018. Exposures: Two International Classification of Diseases, Ninth Revision (ICD-9) codes for PTSD in the same 12 months and obesity, defined by a body mass index of 30 or more or an ICD-9 code for obesity. Main Outcomes and Measures: Incident T2DM, as defined by ICD-9 codes. Results: Among 2204 patients without PTSD, the mean (SD) age was 47.7 (14.3) years; 1860 (84.4%) were men, 1426 (64.7%) were white, and 956 (43.4%) were married. Among 3450 patients with PTSD, the mean (SD) age was 42.8 (14.2) years; 2983 (86.5%) were men, 2238 (64.9%) were white, and 1525 (44.2%) were married. The age-adjusted association between PTSD and incident T2DM was significant (hazard ratio [HR], 1.33 [95% CI, 1.08-1.64]; P = .01), and after adding obesity to the model, this association was reduced and no longer significant (HR, 1.16 [95% CI, 0.94-1.43]; P = .18). Results of the full model, which included additional covariate adjustment, revealed no association between PTSD and incident T2DM (HR, 0.84 [95% CI, 0.64-1.10]; P = .19). Among patients with PTSD with obesity, the age-adjusted incidence of T2DM was 21.0 per 1000 person-years vs 5.8 per 1000 person-years in patients without obesity. In patients without PTSD, it was 21.2 per 1000 person-years for patients with obesity vs 6.4 per 1000 person-years in those without obesity. Conclusions and Relevance: In this study of patients who use the Veterans Health Administration for health care, obesity moderated the association between PTSD and incident T2DM. The incidence of T2DM in patients with PTSD who are not obese is similar to the national incidence rate in the United States. These results suggest PTSD is not likely to have a causal association with incident T2DM. Future research is needed to determine if PTSD remission can lead to weight loss and reduced T2DM incidence.
Authors: Susan M Frayne; Donald R Miller; Erica J Sharkansky; Valerie W Jackson; Fei Wang; Jewell H Halanych; Dan R Berlowitz; Boris Kader; Craig S Rosen; Terence M Keane Journal: Am J Med Qual Date: 2009-10-23 Impact factor: 1.852
Authors: Viola Vaccarino; Jack Goldberg; Kathryn M Magruder; Christopher W Forsberg; Matthew J Friedman; Brett T Litz; Patrick J Heagerty; Grant D Huang; Theresa C Gleason; Nicholas L Smith Journal: J Psychiatr Res Date: 2014-06-09 Impact factor: 4.791
Authors: Andrea L Roberts; Jessica C Agnew-Blais; Donna Spiegelman; Laura D Kubzansky; Susan M Mason; Sandro Galea; Frank B Hu; Janet W Rich-Edwards; Karestan C Koenen Journal: JAMA Psychiatry Date: 2015-03 Impact factor: 21.596
Authors: K C Koenen; J A Sumner; P Gilsanz; M M Glymour; A Ratanatharathorn; E B Rimm; A L Roberts; A Winning; L D Kubzansky Journal: Psychol Med Date: 2016-10-04 Impact factor: 7.723
Authors: Shira Maguen; Katherine D Hoerster; Alyson J Littman; Elizabeth A Klingaman; Gina Evans-Hudnall; Rob Holleman; H Myra Kim; David E Goodrich Journal: J Affect Disord Date: 2016-01-06 Impact factor: 4.839
Authors: Darren W Holowka; Brian P Marx; Margaret A Gates; Heather J Litman; Gayatri Ranganathan; Raymond C Rosen; Terence M Keane Journal: J Consult Clin Psychol Date: 2014-04-14
Authors: Carissa van den Berk-Clark; Scott Secrest; Jesse Walls; Ellen Hallberg; Patrick J Lustman; F David Schneider; Jeffrey F Scherrer Journal: Health Psychol Date: 2018-05 Impact factor: 4.267
Authors: T W McGlennon; J N Buchwald; Walter J Pories; Fang Yu; Arthur Roberts; Eric P Ahnfeldt; Rukmini Menon; Henry Buchwald Journal: Obes Surg Date: 2021-01-06 Impact factor: 4.129
Authors: Jeffrey F Scherrer; Joanne Salas; Kathleen M Chard; Peter Tuerk; Carissa van den Berk-Clark; F David Schneider; Beth E Cohen; Patrick J Lustman; Paula P Schnurr; Matthew J Friedman; Sonya B Norman Journal: J Psychosom Res Date: 2019-10-15 Impact factor: 3.006
Authors: Jeffrey F Scherrer; Joanne Salas; Beth E Cohen; Paula P Schnurr; F David Schneider; Kathleen M Chard; Peter Tuerk; Matthew J Friedman; Sonya B Norman; Carissa van den Berk-Clark; Patrick J Lustman Journal: J Am Heart Assoc Date: 2019-02-19 Impact factor: 5.501
Authors: Jose A Betancourt; Paula Stigler Granados; Gerardo J Pacheco; Ramalingam Shanmugam; C Scott Kruse; Lawrence V Fulton Journal: Healthcare (Basel) Date: 2020-06-29
Authors: Farrukh M Koraishy; Joanne Salas; Thomas C Neylan; Beth E Cohen; Paula P Schnurr; Sean Clouston; Jeffrey F Scherrer Journal: Chronic Stress (Thousand Oaks) Date: 2019-09-30